Technology News and Research

RSS

University of Helsinki researchers develop new method for controlling the activation of genes in a cell

Researchers at the University of Helsinki, Finland, have developed a new method which enables the activation of genes in a cell without changing the genome. Applications of the method include directing the differentiation of stem cells.

9 Sep 2015

AfPA’s video highlights new technology and pill formulations that deter individuals from abusing opioids

Today the Alliance for Patient Access released a new white board video, "A Prescription for Reducing Opioid Abuse." The video, released to coincide with National Pain Awareness Month, highlights new technology and innovative pill formulations that deter individuals from abusing opioids.

9 Sep 2015

Vernalis Therapeutics announces availability of codeine-based cough and cold syrup in the U.S.

Vernalis Therapeutics Inc., a subsidiary of Vernalis plc, today announced that Tuzistra XR (codeine polistirex and chlorpheniramine polistirex), extended-release oral suspension, CIII (DEA Schedule III) is now available to adult patients and physicians in the United States.

8 Sep 2015

Oxis Biotech executes worldwide license agreement to develop, commercialize novel cancer therapy

Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of an exclusive worldwide license agreement to further develop and commercialize DT2219ARL, a novel therapy for the treatment of various human B cell cancers, leukemias and lymphomas.

8 Sep 2015

University of Bonn researchers find how cells in the body can detect genetic material of retroviruses

Researchers at the University of Bonn have discovered how cells in the body can detect the genetic material of so-called retroviruses. The pathogen of the immunodeficiency disease AIDS, the HI-1 virus, also belongs to this group. At the same time, the HI virus appears to circumvent this important defense mechanism.

8 Sep 2015

Demand for improved capabilities, wireless connectivity drives Western and Eastern European MPM market

As the Western European multiparameter patient monitor (MPM) market is in its mature stage, it will generate most of its revenues from replacement units. On the other hand, the Eastern European market, which has not reached maturity, will predominantly see new MPM installations.

8 Sep 2015

CEVEC launches unique cell-expression system for scalable production of gene therapy vectors

CEVEC Pharmaceuticals GmbH, the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced the introduction of its unique cell-expression system, CAP GT, for the fully scalable production of gene therapy vectors, based on the Company's proprietary CAP technology.

8 Sep 2015

AMRA, Pfizer collaborate to assess fat and muscle measurements to predict obesity, diabetes

AMRA announced that they have entered into a unique international collaboration with Pfizer Inc. to investigate the relationship between fat and muscle distribution in the body and metabolic health, including risk factors for conditions such as obesity and diabetes.

8 Sep 2015

Offers from Eppendorf Advantage to improve laboratory efficiency

For researchers and technicians requiring the highest levels of confidence, accuracy, and reliability, the latest Eppendorf Advantage™ offers provide premium solutions for greater laboratory efficiency. Customers can benefit from savings of up to 30% off selected products, until December 2015. In line with their renowned expertise, Eppendorf continues to provide the high-quality solutions for cell biology processes.

7 Sep 2015

Optimising Insulin Pump Therapy symposium to be held in Stockholm on 14 September, 2015

A symposium on optimising insulin pump therapy, particularly focused on infusion set failures, will be held in advance of the 51st European Association for the Study of Diabetes Annual Meeting on 14th September 2015 in Stockholm.

7 Sep 2015

Thoratec begins SHIELD II U.S. clinical trial to examine use of HeartMate PHP in patients undergoing high-risk PCI

Thoratec Corporation, a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today that it has begun enrollment in the SHIELD II U.S. clinical trial examining the HeartMate PHP in patients undergoing a high-risk PCI (percutaneous coronary intervention) procedure.

4 Sep 2015

New findings hold promising implications for blindness caused by limbal stem cell deficiency

Researchers at the University of Oslo have made discoveries that can have great consequences for the treatment of blindness caused by so-called limbal stem cell deficiency.

4 Sep 2015

Current school and university start times linked to poor learning, health problems

A study by researchers from the University of Oxford, Harvard Medical School and the University of Nevada has found that current school and university start times are damaging the learning and health of students.

4 Sep 2015

Researchers find intrinsic differences in mice’s neural stem cells using image-tracking technology

One of the longstanding debates in science, that has, perhaps unsurprisingly, permeated into the field of stem cell research, is the question of nature versus nurture influencing development.

4 Sep 2015

Emdeon to be rebranded as ‘Change Healthcare’ to better reflect its diverse capabilities, solutions

Emdeon, one of the largest, independent healthcare technology companies providing software and analytics, connectivity, communications, payments, consumer engagement and workflow optimization solutions, today announced that the company will rebrand as "Change Healthcare" to better reflect its diverse capabilities and solutions.

4 Sep 2015

Allergan enters into agreement to acquire Aquesys and its XEN45 program

Allergan plc, a leading global pharmaceutical company, and AqueSys, Inc. a private clinical stage medical device company focused on developing ocular implants that reduce intraocular pressure (IOP) associated with glaucoma, today announced that they have entered into an agreement under which Allergan will acquire AqueSys in an all-cash transaction.

4 Sep 2015

Cipla enters into definitive agreements to acquire two US-based companies

Cipla, a global pharmaceutical company which uses technology and innovation to meet the everyday needs of all patients, today announced that its UK arm, Cipla EU has entered into definitive agreements to acquire two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals Inc.

4 Sep 2015

Quest Diagnostics receives FDA 510(k) clearance for Simplexa HSV 1 & 2 Direct molecular test

Quest Diagnostics, the world’s leading provider of diagnostic information services, today announced that its Focus Diagnostics products business has received FDA 510(k) clearance to add the genital swab claim to its Simplexa HSV 1 & 2 Direct molecular test on the Integrated Cycler.

From Quest Diagnostics 4 Sep 2015

Trajan launches prototype blood collection and storage device, hemaPEN

In a world where health care costs are escalating and demands on health care systems are becoming overwhelming, Trajan Scientific and Medical (Trajan) today announces the innovation of hemaPEN, a prototype blood collection and storage device.

4 Sep 2015

Four Next-Generation Preclinical Imaging Systems introduced

Bruker today introduces four important new preclinical imaging systems at the World Molecular Imaging Congress 2015

From Bruker BioSpin Group 3 Sep 2015

Technology News and Research

University of Helsinki researchers develop new method for controlling the activation of genes in a cell

AfPA’s video highlights new technology and pill formulations that deter individuals from abusing opioids

Vernalis Therapeutics announces availability of codeine-based cough and cold syrup in the U.S.

Oxis Biotech executes worldwide license agreement to develop, commercialize novel cancer therapy

University of Bonn researchers find how cells in the body can detect genetic material of retroviruses

Demand for improved capabilities, wireless connectivity drives Western and Eastern European MPM market

CEVEC launches unique cell-expression system for scalable production of gene therapy vectors

AMRA, Pfizer collaborate to assess fat and muscle measurements to predict obesity, diabetes

Offers from Eppendorf Advantage to improve laboratory efficiency

Optimising Insulin Pump Therapy symposium to be held in Stockholm on 14 September, 2015

Thoratec begins SHIELD II U.S. clinical trial to examine use of HeartMate PHP in patients undergoing high-risk PCI

New findings hold promising implications for blindness caused by limbal stem cell deficiency

Current school and university start times linked to poor learning, health problems

Researchers find intrinsic differences in mice’s neural stem cells using image-tracking technology

Emdeon to be rebranded as ‘Change Healthcare’ to better reflect its diverse capabilities, solutions

Allergan enters into agreement to acquire Aquesys and its XEN45 program

Cipla enters into definitive agreements to acquire two US-based companies

Quest Diagnostics receives FDA 510(k) clearance for Simplexa HSV 1 & 2 Direct molecular test

Trajan launches prototype blood collection and storage device, hemaPEN

Four Next-Generation Preclinical Imaging Systems introduced

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News